Cancer cells exhibit a high rate of division and require a substantial amount of nucleotides for DNA replication and repair. Enhanced nucleotide synthesis is crucial for sustaining the rapid proliferation of cancer cells. This increased demand is often met by upregulating the de novo synthesis pathway, which can lead to altered metabolic activity and contribute to the metabolic reprogramming observed in cancer.
